191 related articles for article (PubMed ID: 23934411)
21. Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.
Veuger SJ; Durkacz BW
DNA Repair (Amst); 2011 Feb; 10(2):235-44. PubMed ID: 21144805
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic effects of temozolomide and radiation are additive- and schedule-dependent.
Chalmers AJ; Ruff EM; Martindale C; Lovegrove N; Short SC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1511-9. PubMed ID: 19931733
[TBL] [Abstract][Full Text] [Related]
23. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
[TBL] [Abstract][Full Text] [Related]
24. Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation.
Fokas E; Prevo R; Pollard JR; Reaper PM; Charlton PA; Cornelissen B; Vallis KA; Hammond EM; Olcina MM; Gillies McKenna W; Muschel RJ; Brunner TB
Cell Death Dis; 2012 Dec; 3(12):e441. PubMed ID: 23222511
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibition of ataxia-telangiectasia mutated exacerbates acute kidney injury by activating p53 signaling in mice.
Uehara M; Kusaba T; Ida T; Nakai K; Nakata T; Tomita A; Watanabe-Uehara N; Ikeda K; Kitani T; Yamashita N; Kirita Y; Matoba S; Humphreys BD; Tamagaki K
Sci Rep; 2020 Mar; 10(1):4441. PubMed ID: 32157166
[TBL] [Abstract][Full Text] [Related]
26. ATM-dependent hyper-radiosensitivity in mammalian cells irradiated by heavy ions.
Xue L; Yu D; Furusawa Y; Cao J; Okayasu R; Fan S
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):235-43. PubMed ID: 19695441
[TBL] [Abstract][Full Text] [Related]
27. Exposure to fractionated dose of 60 Gy affects molecular response of HL-60 cells to irradiation.
Vávrová J; Tichý A; Rezáčová M; Zárybnická L; Sinkorová Z; Osterreicher J
Gen Physiol Biophys; 2010 Sep; 29(3):275-81. PubMed ID: 20817951
[TBL] [Abstract][Full Text] [Related]
28. DNA-dependent protein kinase: effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell lines.
Sak A; Groneberg M; Stuschke M
Int J Radiat Biol; 2019 Sep; 95(9):1205-1219. PubMed ID: 31287365
[No Abstract] [Full Text] [Related]
29. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
Teng PN; Bateman NW; Darcy KM; Hamilton CA; Maxwell GL; Bakkenist CJ; Conrads TP
Gynecol Oncol; 2015 Mar; 136(3):554-61. PubMed ID: 25560806
[TBL] [Abstract][Full Text] [Related]
30. Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors.
Wang WT; Catto JW; Meuth M
Oncogene; 2015 May; 34(22):2887-96. PubMed ID: 25043304
[TBL] [Abstract][Full Text] [Related]
31. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
Cui Y; Palii SS; Innes CL; Paules RS
Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
Hickson I; Zhao Y; Richardson CJ; Green SJ; Martin NM; Orr AI; Reaper PM; Jackson SP; Curtin NJ; Smith GC
Cancer Res; 2004 Dec; 64(24):9152-9. PubMed ID: 15604286
[TBL] [Abstract][Full Text] [Related]
33. Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.
Jette NR; Radhamani S; Arthur G; Ye R; Goutam S; Bolyos A; Petersen LF; Bose P; Bebb DG; Lees-Miller SP
Br J Cancer; 2019 Oct; 121(7):600-610. PubMed ID: 31481733
[TBL] [Abstract][Full Text] [Related]
34. Ataxia-telangiectasia mutated (ATM) participates in the regulation of ionizing radiation-induced cell death via MAPK14 in lung cancer H1299 cells.
Liang N; Zhong R; Hou X; Zhao G; Ma S; Cheng G; Liu X
Cell Prolif; 2015 Oct; 48(5):561-72. PubMed ID: 26269117
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis.
Qi W; Xu X; Wang M; Li X; Wang C; Sun L; Zhao D; Sun L
Biochem Pharmacol; 2019 Jun; 164():273-282. PubMed ID: 31014753
[TBL] [Abstract][Full Text] [Related]
36. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells.
Sanli T; Rashid A; Liu C; Harding S; Bristow RG; Cutz JC; Singh G; Wright J; Tsakiridis T
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):221-9. PubMed ID: 20615625
[TBL] [Abstract][Full Text] [Related]
37. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
38. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
40. RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation.
Yan Y; Greer PM; Cao PT; Kolb RH; Cowan KH
Breast Cancer Res; 2012 Apr; 14(2):R60. PubMed ID: 22494620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
